Sign In
Buy FMS
$20.90
+0.350 (+1.70%)
At Close: Jun 03, 2026
Reasons to Retain Fresenius Medical Stock in Your Portfolio Now
10:16am, Friday, 27'th Sep 2024
FMS continues to gain traction on the back of its broad dialysis product and service portfolio. Ongoing macro challenges raise concerns.
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
10:41am, Friday, 20'th Sep 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Fresenius (FMS) is a Top Momentum Stock for the Long-Term
10:56am, Wednesday, 18'th Sep 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Fresenius Medical Care Stock Rises on NxStage VersiHD Launch
01:50pm, Monday, 09'th Sep 2024
FMS introduces NxStage VersiHD with GuideMe Software to simplify home dialysis and grow its patient base in the United States.
Fresenius Medical Care achieves growth milestone of more than 14,000 U.S.-based patients using the Company's NxStage systems to perform Home Hemodialysis therapy This growth has generated greater adop
Reasons to Retain Fresenius Medical Stock in Your Portfolio Now
11:01am, Tuesday, 27'th Aug 2024
FMS continues to gain traction through its broad dialysis product and service portfolio. Ongoing macro challenges raise concerns.
Marvell to Showcase Latest Cloud Storage and CXL Memory Technologies at FMS 2024
09:00am, Wednesday, 07'th Aug 2024
Awarded Most Innovative Sustainability Technology for Marvell® Structera™ X CXL Memory-Expansion Controller SANTA CLARA, Calif. , Aug. 7, 2024 /PRNewswire/ -- Marvell Technology, Inc. (NASDAQ: MRVL
Fresenius Medical Care CEO says strategy is working as company delivers on transformation efforts
09:30pm, Tuesday, 30'th Jul 2024
Fresenius Medical Care CEO Helen Giza comments on the firm's second-quarter earning results.
Fresenius Medical (FMS) Q2 Earnings In Line, Operating Margin Up
02:35pm, Tuesday, 30'th Jul 2024
Fresenius Medical's (FMS) second-quarter revenues suffer due to divestures. However, the company?
Fresenius Medical Care AG (FMS) Q2 2024 Earnings Call Transcript
12:39pm, Tuesday, 30'th Jul 2024
Fresenius Medical Care AG (NYSE:FMS ) Q2 2024 Earnings Call July 30, 2024 8:00 AM ET Company Participants Dominik Heger - Head, Investor Relations Helen Giza - Chief Executive Officer and Chair Martin
Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024
07:00am, Tuesday, 30'th Jul 2024
Organic revenue growth of +2.3% supported by both segments Care Delivery and Care Enablement Operating income1 and operating income margin1 increase driven by Care Enablement Additional FME25 savings
Here's Why Fresenius (FMS) is a Strong Value Stock
10:40am, Tuesday, 23'rd Jul 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
US FTC probing DaVita, Fresenius Medical, Politico reports
09:16am, Saturday, 13'th Jul 2024
The U.S. Federal Trade Commission (FTC) is investigating healthcare providers DaVita and Fresenius Medical Care over allegations that the companies have been illegally thwarting smaller competitors, P
Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now
09:00am, Monday, 08'th Jul 2024
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
BELGRADE, Mont., July 01, 2024 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. (“Bridger”, “the Company” or “Bridger Aerospace”), (NASDAQ: BAER, BAERW), one of the nation's larg
